Goldman Sachs’s Shuttle Pharmaceuticals SHPH Stock Holding History

Goldman Sachs’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	-$24.4K	–	6194
2022 Q4	$24.4K	Buy	+6	New	+$29.2K	﹤0.01%	5683

Other funds holding SHPH

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Goldman Sachs's SHPH Position: Q1 2023 in Review

Goldman Sachs sold out of Shuttle Pharmaceuticals (SHPH) in Q1 2023, closing a stake of 6 shares — an estimated $24.4K sold.

Goldman Sachs first reported a position in SHPH in Q4 2022 and held it in 1 quarter. The position peaked at $24.4K in Q4 2022. 3 funds tracked by Wall St. Rank hold SHPH as of Q1 2023.

Goldman Sachs reported no remaining Shuttle Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 6 Shuttle Pharmaceuticals shares in Q1 2023, an estimated $24.4K.
Goldman Sachs first reported a position in Shuttle Pharmaceuticals in Q4 2022 and held it in 1 quarter.
Goldman Sachs's Shuttle Pharmaceuticals position peaked at $24.4K in Q4 2022.
3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.